Trial intelligence / Profile preview

End-tidal carbon dioxide in septic shock: norepinephrine versus dopamine

IRCT2015101924606N1Phase 3Completed

Sponsor
Mazandaran University of Medical Sciences
Start
Feb 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in septic shock comparing Norepinephrine arm with Dopamine arm (2 arms). Primary endpoint: End-tidal carbon dioxide measurement. Started Feb 2016; status: completed.

02

Drugs

norepinephrinedopamine
03

Conditions

septic shock

Beyond the preview

Go deeper on IRCT2015101924606N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2015101924606N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call